Cardlytics, INC Form 4 insider transactions

Director Scott A. Hill reports the vesting and conversion of restricted stock units into Cardlytics common stock.

Director Liane Hornsey reports the vesting and conversion of restricted stock units into 11,000 shares of Cardlytics (CDLX) common stock on May 23, 2025.

Director Jonathan Edward Francis reports the vesting and conversion of restricted stock units into common stock.

Director John L. Klinck Jr. reports the vesting and conversion of restricted stock units into Cardlytics common stock.

Director Andre J. Fernandez reports the vesting and disposal of 11,000 restricted stock units into Cardlytics common stock on May 23, 2025.

Director Andre J. Fernandez acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date.

Director John L. Klinck Jr. reports acquisition of 11,000 restricted stock units in Cardlytics, Inc.

Director Jonathan Edward Francis acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, according to a Form 4 filing.

Director Liane Hornsey acquired 11,000 restricted stock units (RSUs) of Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date, provided she remains a director.

Director Scott A. Hill acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date.

Director Srishti A. Gupta acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date.

Cardlytics' Chief Financial Officer, Alexis DeSieno, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Cardlytics' Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Director Liane Hornsey reports the vesting of restricted stock units into Cardlytics common stock.

Cardlytics CEO Amit Gupta reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Cardlytics' Chief Financial Officer, Alexis DeSieno, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Cardlytics' Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Cardlytics' Chief Financial Officer, Alexis DeSieno, was granted performance-based and time-based restricted stock units on March 19, 2025.

Chief Legal & Privacy Officer of Cardlytics, Inc., Nicholas Hollmeyer Lynton, reports the acquisition of performance stock units and restricted stock units.

Cardlytics CEO Amit Gupta sold shares of common stock to cover tax obligations resulting from the vesting of restricted stock units (RSUs).

Cardlytics' Chief Financial Officer, Alexis DeSieno, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Cardlytics' Chief Legal & Privacy Officer, Nicholas Lynton, reports the acquisition of 6,312 shares through performance stock units and the subsequent sale of 3,377 shares to cover tax obligations.

Cardlytics CEO, Amit Gupta, was granted 500,000 restricted stock units (RSUs) that will vest over 24 months.

Cardlytics CEO Amit Gupta sold 15,160 shares of common stock at an average price of $3.92 to cover tax obligations following the vesting of restricted stock units.

Cardlytics' Chief Financial Officer, Alexis DeSieno, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Cardlytics' Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, reports the vesting and sale of common stock to cover tax obligations.

Director Andre J. Fernandez reports the vesting and acquisition of 4,310 shares of Cardlytics, Inc. common stock on January 1, 2025, through the vesting of restricted stock units.

Director Jonathan Edward Francis acquired 4,310 shares of Cardlytics, Inc. common stock through the vesting of restricted stock units.

Cardlytics CEO Amit Gupta acquired shares through vested restricted stock units and sold a portion to cover tax obligations.

Clifford Sosin, a director of Cardlytics, Inc., reported a pro rata distribution of 754,032 common shares and holdings of convertible senior notes through related investment partnerships.